TFC Financial Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

TFC Financial Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294	Hold	1	–	–	﹤0.01%	805
2026 Q1	$279	Hold	1	–	–	﹤0.01%	762
2025 Q4	$303	Hold	1	–	–	﹤0.01%	738
2025 Q3	$281	Hold	1	–	–	﹤0.01%	763
2025 Q2	$242	Buy	+1	New	+$236	﹤0.01%	755
2024 Q4	–	Sell	-3	Closed	-$1K	–	983
2024 Q3	$1K	Buy	+3	New	+$953	﹤0.01%	589
2024 Q2	–	Sell	-3	Closed	-$1.04K	–	985
2024 Q1	$1.04K	Buy	3 +2	+200%	+$658	﹤0.01%	548
2023 Q4	$323	Sell	1 -6	-86%	-$1.88K	﹤0.01%	642
2023 Q3	$2.51K	Hold	7	–	–	﹤0.01%	440
2023 Q2	$2.65K	Buy	+7	New	+$2.85K	﹤0.01%	420

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

TFC Financial Management's BIO Position: Q2 2026 in Review

TFC Financial Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1 share worth $294. The position accounts for ﹤0.01% of the portfolio, ranked #805.

TFC Financial Management first reported a position in BIO in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.65K in Q2 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

TFC Financial Management held 1 share of Bio-Rad Laboratories Class A worth $294 as of Q2 2026.
TFC Financial Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #805 holding.
TFC Financial Management first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and has held it in 10 quarters since.
TFC Financial Management's Bio-Rad Laboratories Class A position peaked at $2.65K in Q2 2023.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.